Subanalyses of non‐motor symptoms and clinical global impression in Spanish advanced Parkinson's disease patients treated with levodopa‐carbidopa intestinal gel: E-DUO Study

Trial Profile

Subanalyses of non‐motor symptoms and clinical global impression in Spanish advanced Parkinson's disease patients treated with levodopa‐carbidopa intestinal gel: E-DUO Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2015

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2015 New trial record
    • 18 Jun 2015 Results of subgroup analysis assessing discontinuation factors presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
    • 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top